Dialysis
Patient education, tailored support can promote home dialysis in certain adults
Patient-centered education and tailored support can promote an uptake of home dialysis among self-identified Hispanic or Latino adults receiving in-center dialysis, according to results of a qualitative study.
Investors back eGenesis in pursuing pig-to-human transplant study
A biotechnology company developing compatible organs for transplantation to humans, eGenesis, secured financial backing that could eventually lead to a human trial of its bioengineered pig kidney, according to a company press release.
CKD-associated pruritus often poorly treated, may disrupt dialysis even when reported
Chronic kidney disease-associated pruritus may often be insufficiently treated and can disrupt dialysis treatment for patients who report itch to health care providers.
AKI may be linked to higher dialysis need, mortality for hospitalized patients
AKI may be liker with a higher need for dialysis and higher mortality for hospitalized patients in a study that compared social determinants of health between patient groups.
Patients drawn to Medicare Advantage benefits, but higher costs, data issues remain
Sources of Healio | Nephrology News & Issues have made it clear that the explosive growth in the number of patients with end-stage kidney disease that join Medicare Advantage plans has overwhelmed everyone — payers and providers alike.
Independent dialysis providers face challenges with patient care under Medicare Advantage
Passage of the 21st Century Cures Act in 2021 allowed Medicare beneficiaries with end-stage kidney disease to enroll in Medicare Advantage plans regardless of their previous coverage or when they were diagnosed.
Senate bill would require health plans to continue dialysis coverage for 30 months
A bipartisan bill introduced in the U.S. Senate would require private health plans to continue to pay for dialysis for beneficiaries with end-stage kidney disease while they coordinate a transition to Medicare coverage.
Decision factors for pediatric kidney replacement therapies may differ from guidelines
Level of kidney function, rate of decline and type of renal disease are key factors influencing the decision to initiate kidney replacement therapy, whether dialysis or transplantation, for pediatric patients, according to study data.
Quality improvement intervention boosted education in patients with kidney disease
A quality improvement intervention successfully boosted education among patients with kidney disease but did not achieve higher home dialysis choice rates, according to study results.
Akebia readies launch of anemia drug Vafseo; planning talks with FDA on pre-dialysis use
As Akebia Therapeutics announced plans to launch its anemia drug Vafseo to the dialysis community, company officials said they intend to work with the FDA for more testing of the drug for the pre-dialysis market.